Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{204644,
        author = {Gonna Navya sree},
        title = {Regulatory Compliance in The Pharmaceutical Sector: Its Role, Challenges, And Impact On Industrial Development And Product Safety},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {1},
        pages = {3409-3413},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=204644},
        abstract = {Regulatory compliance forms the foundation of pharmaceutical quality assurance and public health protection. The pharmaceutical industry operates within a highly regulated environment because medicines directly affect human life and health. Regulatory systems have evolved globally in response to safety concerns, technological developments, and increasing complexities in pharmaceutical manufacturing and distribution. The present review examines the role of regulatory compliance in ensuring drug safety, efficacy, and quality while assessing its influence on industrial development and international competitiveness. The study explores the evolution of pharmaceutical regulations, the structure of regulatory authorities, international regulatory frameworks, challenges faced by developing nations, and the impact of compliance requirements on innovation and market access. Evidence suggests that robust regulatory systems improve public confidence, reduce counterfeit medicines, and promote global trade. However, excessive regulatory burdens may increase development costs, prolong approval timelines, and create barriers for small and medium-sized pharmaceutical enterprises. Regulatory harmonization initiatives such as those promoted by the International Council for Harmonisation (ICH) and the World Health Organization (WHO) have significantly reduced regulatory duplication and improved international cooperation. The study concludes that balanced regulatory frameworks are essential for safeguarding public health while simultaneously encouraging innovation, economic growth, and sustainable pharmaceutical development.},
        keywords = {Regulatory compliance, pharmaceutical regulation, Drug safety, Quality assurance, Regulatory affairs, Product safety, Industrial development.},
        month = {June},
        }